The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Real world evidence from a retrospective multi-center analysis on first-line therapy for metastatic renal cell carcinoma with non-clear cell and/or sarcomatoid histologies.
 
Pia Paffenholz
Honoraria - BMS GmbH & Co. KG; Eisai; Janssen; Merck
Consulting or Advisory Role - Janssen; Merck; Roche
Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca; Ipsen; Janssen; Medac; Merck
 
Stefanie Zschaebitz
Honoraria - Amgen; Astellas Pharma; Bayer; BMS GmbH & Co. KG; Eisai Germany; Ipsen; Janssen Oncology; Merck Serono; MSD Oncology; Novartis; Pfizer (Inst)
Consulting or Advisory Role - Amgen; Astellas Pharma (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Eisai; EUSA Pharma; Gilead Sciences; Ipsen; Merck; MSD Oncology; Pfizer (Inst); Roche; Sanofi/Aventis (Inst)
Research Funding - Eisai (Inst)
Travel, Accommodations, Expenses - Amgen; Astellas Pharma; BMS GmbH & Co. KG; Ipsen; Janssen Oncology; Merck; Pfizer
 
Jozefina Casuscelli
Research Funding - AstraZeneca (Inst); MSD Oncology (Inst)
Expert Testimony - Astellas Pharma; Janssen Cilag; MSD Oncology
Travel, Accommodations, Expenses - Bayer; Janssen Oncology; Merck KGaA; Pfizer
 
Emily Rinderknecht
No Relationships to Disclose
 
Angelika Mattigk
No Relationships to Disclose
 
Melis Gür
No Relationships to Disclose
 
Philipp Ivanyi
Stock and Other Ownership Interests - BB Biotech Ventures
Honoraria - AIMM Therapeutics; Bayer/Vital; Bristol-Myers Squibb; Eisai; EUSA Pharma; Ipsen; Merck Serono; MSD Oncology; Roche Pharma AG
Consulting or Advisory Role - Bayer/Vital; Bristol-Myers Squibb; Eisai; Ipsen; Merck Serono; MSD; Pfizer
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Ipsen
Other Relationship - Merck Serono; Pfizer
 
Thomas Hilser
No Relationships to Disclose
 
Christopher Darr
Honoraria - Bayer; Ipsen; Janssen
Consulting or Advisory Role - Ipsen; Janssen
Research Funding - Deutsche Forschungsgemeinschaft (Inst)
Travel, Accommodations, Expenses - Ipsen; Janssen
 
Subhajit Mandal
No Relationships to Disclose
 
Katrin Schlack
Honoraria - AAA HealthCare; Amgen (Inst); Astellas Pharma; AstraZeneca; Bayer Germany; Eisai Germany; Fosanis; Ipsen; Janssen; Merck Serono; MSD; Novartis; Pfizer
Consulting or Advisory Role - Apogepha; Bayer; BMS GmbH & Co. KG; Ipsen; Janssen; Pfizer
Travel, Accommodations, Expenses - AstraZeneca; Bayer; Ipsen; Janssen; Pfizer
 
Daniel Seidl
No Relationships to Disclose
 
Analena Handke
No Relationships to Disclose
 
Melanie Klee
No Relationships to Disclose
 
Tim Nestler
Consulting or Advisory Role - Janssen
Speakers' Bureau - Janssen
 
Marc Rehlinghaus
Consulting or Advisory Role - Bayer; IPSEN,; Merck
Speakers' Bureau - Astellas Oncology; Bayer; Merck; Reuter Medico Consulting
Travel, Accommodations, Expenses - Bayer; IPSEN,; Merck
 
Sameh Hijazi
No Relationships to Disclose
 
Axel Heidenreich
Honoraria - Amgen; Astellas Pharma; Bayer; Ferring; Ipsen; Janssen-Cilag; Sanofi; Takeda
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; BMS Global; Clovis Oncology; Janssen-Cilag; MSD Oncology
Speakers' Bureau - Amgen; Astellas Pharma; Bayer; Ipsen; Johnson & Johnson; Pfizer; Sanofi; Takeda
Research Funding - Astellas Pharma; Bayer; BMS Oncology; Sanofi
 
Viktor Grünwald
Employment - University Hospital Essen
Stock and Other Ownership Interests - AstraZeneca; Bristol-Myers Squibb; Genmab; MSD; Seagen
Honoraria - Advanced Accelerator Applications/Novartis; Amgen; Apogepha; Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Eisai; EUSA Pharma; Ipsen; Janssen-Cilag; Merck Serono; MSD Oncology; Nanobiotix; Ono Pharmaceutical; Pfizer
Consulting or Advisory Role - Bristol-Myers Squibb; Cor2Ed; Cureteq; Debiopharm Group; Eisai; Gilead Sciences; Ipsen; Janssen-Cilag; MSD Oncology; Novartis; Oncorena; Onkowissen; PCI Biotech; Pfizer; Synthekine
Research Funding - Amgen (Inst); BMS (Inst); Gilead Sciences (Inst); Ipsen (Inst); MSD Oncology (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Janssen; Merck Serono; Pfizer
 
Martin Schostak
Honoraria - AstraZeneca; Bayer; Janssen Oncology; Merck; Novartis; Pfizer
Consulting or Advisory Role - Astellas Amgen BioPharama; AstraZeneca; BMS GmbH & Co. KG; EDAP TMS; IPSEN,; IPSEN,; Janssen Oncology; MSD Oncology; Pfizer; Sanofi
Research Funding - AstraZeneca; Bayer; BMS GmbH & Co. KG; IPSEN,; Janssen Oncology; MSD Oncology; Sanofi
Travel, Accommodations, Expenses - AstraZeneca; Bayer; BMS GmbH & Co. KG; Merck; MSD; Pfizer; Sanofi